Sigachi Industries Limited · NSE:SIGACHI
Sigachi Industries — Q3 FY2024 Earnings Presentation
21 slides from Sigachi Industries's earnings presentation, Jan 19, 2024
Slide 1: Cover letter to stock exchanges for Q3 FY24 investor presentation
SIGACHI INDUSTRIES LIMITED CIN: L24110TG1989PLC009497 AN EXCiPACT GMP, ISO 9001:2015 &FSSC 22000 CERTIFIED COMPANY s To, Date: 19-01-2024 The Manager The Manager, BSE Limited NSE Limited, P. J. Towers, Dalal Street Exchange Plaza, Bandra Kurla Complex, Mumbai-400001 Bandra (E), Mumbai- 400051. (BSE
Slide 2: Sigachi Industries Limited Earnings Presentation Q3/9M-FY24
Sigachi Industries Limited Earnings Presentation Q3/9M-FY24
Slide 3: Disclaimer
Disclaimer Sigachi Industries Limited Disclaimer: No representation or warranty, express or implied, is made as to, and no reliance should be placed on the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are
Slide 4: Company At A Glance
Company At A Glance 3 5 60 + 337+ Decades of State-of-the art Widely used Customers across expertise manufacturing excipients 52 countries facilities 29.5% 33.3% 29% 0.03x 3 Years Revenue 3 Years EBITDA 3 Years PAT Net Debt-to-Equity CAGR CAGR CAGR Ratio (FY23) 3
Slide 5: Business Overview
Business Overview Global Leader in MCC State-of-the-Art Facilities in Production Gujarat , Telangana and Karnataka. Key Application Areas: Pharmaceuticals, Supplements, Ensuring a Reliable and Efficient Food Industries Global Supply Chain Leading Manufacturer of Strategic Expansion into API Innovati
Slide 6: Strategic Priorities
Strategic Priorities Current Capacity Upcoming Diversifying Pharma • Manufacture higher-grade products and 14,000 MTPA 7,200 MTPA Product Mix: introduce innovative value-added items. 6,400 MTPA • Prioritize MCC manufacturing for diverse Core Business Focus industries, optimizing resource utilization
Slide 7: Well-Invested Infrastructure, Seamless Operations
Well-Invested Infrastructure, Seamless Operations 5 State of the art facilities with combined capacity of over 14,000 + MTPA including 2 R&D hubs for Quality Assurance 96.17 % 96.65 % 92.58 % 6,400 MTPA 4,800 MTPA 2,800 MTPA Dahej Jhagadia Hyderabad Dahej Jhagadia Hyderabad Capacity utilization in %
Slide 8: Global Presence
Global Presence Diversified Revenue Stream (FY23) Industries we cater to … Markets we are present in … 2% 2% 2% 5% 2% 3% 5% 26% 20% 12% 75% 15% 20% Pharmeceutical Food & Nutra Cosmetics India United States Australia Sweden Denmark Egypt China Spain United Kingdom Poland 7
Slide 9: Core Competencies
Core Competencies Product Tailor made products for diverse industries, Customization meeting unique specifications. MCC Manufacture MCC in various grades (15 Manufacturing microns to 250 microns), ensuring a Expertise comprehensive offering. Key Customer-Centric Maintain strong relationships with cu
Slide 10: Growing Topline
Growing Topline Total Revenue from MCC (Rs Mn) Total Revenue from Operations (Rs Mn) 3,500 CAGR 23 % CAGR 29 % 3,020 2,948 3,000 2,602 2,503 2,500 2,265 2,232 2,000 1,806 1,928 1,500 1,287 1,391 1,000 500 0 FY20 FY21 FY22 FY23 9M FY24 FY20 FY21 FY22 FY23 9MFY24 9
Slide 11: Enabling Prudent Capital Allocation
Sustained Margin, Robust Cash Flow Sustained EBITDA (Rs Mn) Capex (Rs Mn) Enabling Prudent Capital Allocation 587 603 531 388 260 248 FY19 FY20 FY21 FY22 FY23 9M FY24 750 Robust Cash Flow (Rs Mn) 500 243 296 290 93 145 121 FY21 FY22 FY23 FY24E 59 FY19 FY20 FY21 FY22 FY23 10
Slide 12: Financial Overview
Financial Overview
Slide 13: Q3 & 9MFY24 Financial Highlights
Q3 & 9MFY24 Financial Highlights Revenue from Operations (Rs Mn) EBITDA (Rs Mn) & EBITDA Margin (%) PAT (Rs Mn) & PAT Margin (%) 20.35% 20.38% 14.24% 14.61% 61.19% 61.42% 65.3% Q3FY24 1,109 226 162 688 140 98 Q3FY23 Q3FY24 Q3FY23 Q3FY24 Q3FY23 Q3FY24 20.25% 20.45% 15.77% 14.24% 28.40% 29.68% 16.02%
Slide 14: 9M FY24 Operational and Strategic Highlights
9M FY24 Operational and Strategic Highlights The overall revenue in 9M Period ended experienced a robust YoY growth of 27.5%, escalating from INR 2,347 Million to INR 2,992 Million. The quantity of MCC demonstrated a notable YoY growth of 12.04%, increasing from 9851 MT to 11,036 MT in 9M FY 24 comp
Slide 15: Q3FY24 Consolidated Income Statement
Q3FY24- Consolidated Income Statement Particulars (INR Mn) Q3-FY24 Q3-FY23 Y-o-Y Q2-FY24 Q-o-Q Operational Revenue 1,109 688 61.19% 992 11.79% Total Expenses 883 548 61.13% 778 13.49% EBITDA 226 140 61.42% 214 5.60% EBITDA Margin (%) 20.38% 20.35% 3Bps 21.67% -129 Bps Depreciation and amortisation 2
Slide 16: 9M FY24 Consolidated Income Statement
9M FY24 – Consolidated Income Statement Particulars (INR Mn) 9M FY24 9M FY23 Y-o-Y Operational Revenue 2,948 2,296 28.40% Total Expenses 2,345 1,831 28.07% EBITDA 603 465 29.68% EBITDA Margin (%) 20.45% 20.25% 20Bps Depreciation and amortisation 73 46 Finance costs 49 29 Other Income 44 51 PBT 525 4
Slide 17: Historical Consolidated Financial Performance
Historical Consolidated Financial Performance Particulars (INR Mn) FY21 FY22 FY23 9M FY24 Operational Revenue 1,928 2,503 3,020 2,948 Total Expenses 1,540 1,972 2,433 2,345 EBITDA 388 531 587 603 EBITDA Margin (%) 20.12% 21.21% 19.43% 20.45% Depreciation and amortisation 23 29 66 73 Finance costs 13
Slide 18: Historical Consolidated Balance Sheet
Historical Consolidated Balance Sheet Particulars (INR Mn) FY21 FY22 FY23 H1-FY24 EQUITY 942 2,277 2,683 3,978 Equity Share Capital 77 307 307 307 Other Equity 865 1,970 2,376 3,671 NON-CURRENT LIABILITIES 70 76 308 503 a) Financial Liabilities i) Borrowings 19 12 10 183 ii) Lease Liability - - 231
Slide 19: Historical Consolidated Balance Sheet
Historical Consolidated Balance Sheet Particulars (INR Mn) FY21 FY22 FY23 H1-FY24 NON-CURRENT ASSETS 463 1,069 1,964 3,547 a) Property, plant and equipment 376 527 960 1,702 b) Capital work-in-progress 37 97 349 649 c) Intangible assets 3 7 7 7 d) Goodwill - - - 435 e) Right of Use Assets - - 257 23
Slide 20: Consolidated Financial Highlights
Consolidated Financial Highlights Operational Revenue (INR Mn) EBITDA (Rs Mn) & EBITDA Margin (%) PAT (Rs Mn) & PAT Margin (%) 587 603 436 420 400 531 303 388 20.45% 3,020 2,948 2,503 20.12% 21.21% 19.43% 1,928 15.72% 15.98% 14.43% 14.24% FY21 FY22 FY23 9MFY24 FY21 FY22 FY23 9MFY24 FY21 FY22 FY23 9M
Slide 21: Thank You
GoIndia Advisors – IR Firm Ms. Sheetal Khanduja Ms. Deepika Sharma Ms. Priya Sen sheetal@goindiaadvisors.com deepika@goindiaadvisors.com priya@goindiaadvisors.com M: +91 9769364166 M:+91 8451029510 M : +91 8334841047 Thank You